Kiniksa Pharmaceuticals (KNSA) stock Forecast for 2022 – 2026

Kiniksa Pharmaceuticals (KNSA) stock Forecast for 2022 – 2026

Last update: October 6, 2022 (07:34)

Sector: Healthcare

The share price of Kiniksa Pharmaceuticals, Ltd. (KNSA) now

What analysts predict: $22

52-week high/low: $15.24 / $7.36

50/200 Day Moving Average: $11.54 / $10.59

This figure corresponds to the average price over the previous 50/200 days. For Kiniksa Pharmaceuticals stocks, the 50-day moving average is the support level today.

For Kiniksa Pharmaceuticals stocks, the 200-day moving average is the support level today.

Are you interested in Kiniksa Pharmaceuticals, Ltd. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Kiniksa Pharmaceuticals stock price in 2022, 2023, 2024, 2025, 2026. How much will one Kiniksa Pharmaceuticals share be worth in 2022 - 2026?

When should I take profit in Kiniksa Pharmaceuticals stock? When should I record a loss on Kiniksa Pharmaceuticals stock? What are analysts' forecasts for Kiniksa Pharmaceuticals stock? What is the future of Kiniksa Pharmaceuticals stock?

We forecast Kiniksa Pharmaceuticals stock performance using neural networks based on historical data on Kiniksa Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Kiniksa Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)

The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Kiniksa Pharmaceuticals shares. This happens once a day.





Historical and forecast chart of Kiniksa Pharmaceuticals stock

The chart below shows the historical price of Kiniksa Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Kiniksa Pharmaceuticals stock price can be found in the table below.

Long-term forecasts by years.

Kiniksa Pharmaceuticals daily forecast for a month

Date Target Pes. Opt. Vol., %
Oct 08 14.27 13.89 14.50 4.36
Oct 09 14.27 13.97 14.56 4.29
Oct 10 14.14 13.74 14.31 4.16
Oct 11 13.62 13.38 14.04 4.88
Oct 12 13.81 13.49 13.93 3.32
Oct 13 13.57 13.41 13.91 3.72
Oct 14 13.40 13.13 13.56 3.27
Oct 15 13.20 12.88 13.46 4.51
Oct 16 13.44 13.32 13.75 3.27
Oct 17 13.22 12.89 13.60 5.50
Oct 18 13.32 13.10 13.62 3.98
Oct 19 13.68 13.52 13.85 2.47
Oct 20 13.57 13.32 13.95 4.73
Oct 21 13.34 13.19 13.52 2.55
Oct 22 13.87 13.67 14.30 4.55
Oct 23 13.84 13.44 13.98 4.04
Oct 24 13.69 13.57 14.10 3.91
Oct 25 14.05 13.76 14.48 5.23
Oct 26 13.78 13.42 14.16 5.46
Oct 27 13.52 13.34 13.70 2.68
Oct 28 13.61 13.34 14.04 5.26
Oct 29 13.43 13.01 13.66 5.00
Oct 30 13.55 13.42 13.79 2.79
Oct 31 13.54 13.13 13.78 4.99
Nov 01 13.29 13.01 13.51 3.80
Nov 02 13.61 13.18 14.03 6.44
Nov 03 13.54 13.21 13.73 3.98
Nov 04 13.69 13.57 13.90 2.38
Nov 05 13.84 13.71 13.96 1.86
Nov 06 13.84 13.55 14.18 4.70

Kiniksa Pharmaceuticals Daily Price Targets


Kiniksa Pharmaceuticals Stock Forecast 10-08-2022.

Forecast target price for 10-08-2022: $14.27. Positive dynamics for Kiniksa Pharmaceuticals shares will prevail with possible volatility of 4.175%.

Pessimistic target level: 13.89

Optimistic target level: 14.50


Kiniksa Pharmaceuticals Stock Forecast 10-09-2022.

Forecast target price for 10-09-2022: $14.27. Negative dynamics for Kiniksa Pharmaceuticals shares will prevail with possible volatility of 4.116%.

Pessimistic target level: 13.97

Optimistic target level: 14.56


Kiniksa Pharmaceuticals Stock Forecast 10-10-2022.

Forecast target price for 10-10-2022: $14.14. Negative dynamics for Kiniksa Pharmaceuticals shares will prevail with possible volatility of 3.992%.

Pessimistic target level: 13.74

Optimistic target level: 14.31


Kiniksa Pharmaceuticals Stock Forecast 10-11-2022.

Forecast target price for 10-11-2022: $13.62. Negative dynamics for Kiniksa Pharmaceuticals shares will prevail with possible volatility of 4.657%.

Pessimistic target level: 13.38

Optimistic target level: 14.04


Kiniksa Pharmaceuticals Stock Forecast 10-12-2022.

Forecast target price for 10-12-2022: $13.81. Positive dynamics for Kiniksa Pharmaceuticals shares will prevail with possible volatility of 3.211%.

Pessimistic target level: 13.49

Optimistic target level: 13.93


Kiniksa Pharmaceuticals Stock Forecast 10-13-2022.

Forecast target price for 10-13-2022: $13.57. Negative dynamics for Kiniksa Pharmaceuticals shares will prevail with possible volatility of 3.589%.

Pessimistic target level: 13.41

Optimistic target level: 13.91


KNSA (KNSA) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Nov. 15.53 14.89 16.33 8.79
Dec. 14.91 14.48 15.92 9.00

Kiniksa Pharmaceuticals forecast for this year


Kiniksa Pharmaceuticals Stock Prediction for Nov 2022

An uptrend is forecast for this month with an optimal target price of $15.5278. Pessimistic: $14.89. Optimistic: $16.33


Kiniksa Pharmaceuticals Stock Prediction for Dec 2022

An downtrend is forecast for this month with an optimal target price of $14.9129. Pessimistic: $14.48. Optimistic: $15.92




Kiniksa Pharmaceuticals (KNSA) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 15.66 14.95 16.59 9.86
Feb 14.89 13.96 15.30 8.76
Mar 15.77 14.54 16.17 10.07
Apr 14.82 13.93 16.07 13.28
May 16.21 14.69 16.68 11.90
Jun 16.06 15.42 17.35 11.11
Jul 15.65 14.35 16.97 15.39
Aug 15.97 14.88 17.06 12.80
Sep 15.43 14.86 16.06 7.49
Oct 16.30 14.93 17.15 12.89
Nov 16.46 15.75 17.47 9.84
Dec 16.74 15.17 17.30 12.31

Kiniksa Pharmaceuticals (KNSA) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 18.50 16.97 19.95 14.92
Feb 18.17 16.99 19.72 13.82
Mar 19.00 17.20 20.16 14.70
Apr 18.11 17.28 18.59 7.02
May 18.48 17.62 19.21 8.31
Jun 17.19 16.62 18.72 11.24
Jul 16.37 15.03 17.39 13.55
Aug 16.01 14.75 16.73 11.83
Sep 15.13 13.99 15.91 12.10
Oct 16.75 15.24 17.55 13.17
Nov 18.25 17.77 19.42 8.46
Dec 17.62 16.96 18.25 7.07



Kiniksa Pharmaceuticals (KNSA) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 18.59 16.99 20.24 16.09
Feb 17.54 16.49 18.32 10.00
Mar 16.11 15.32 16.88 9.27
Apr 16.25 15.53 16.77 7.44
May 15.51 14.13 16.49 14.33
Jun 15.36 14.75 16.54 10.81
Jul 14.73 14.25 15.60 8.61
Aug 15.15 14.57 15.63 6.75
Sep 15.88 14.72 16.59 11.26
Oct 16.72 16.12 17.96 10.28
Nov 16.22 15.81 17.08 7.41
Dec 15.95 14.89 16.77 11.18

Kiniksa Pharmaceuticals (KNSA) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 17.82 16.82 18.93 11.18
Feb 16.39 15.56 17.02 8.55
Mar 16.33 14.96 16.76 10.76
Apr 16.29 14.88 16.92 12.02
May 15.61 14.15 16.88 16.20
Jun 17.10 15.61 18.40 15.17
Jul 18.34 17.04 18.86 9.68
Aug 19.33 18.26 20.69 11.77
Sep 19.14 18.34 20.34 9.83
Oct 20.04 19.41 20.69 6.16
Nov 22.08 20.20 23.86 15.33
Dec 20.89 19.71 22.72 13.24

Kiniksa Pharmaceuticals information and performance

Kiniksa Pharmaceuticals, Ltd., a clinical stage biopharmaceutical company, specializes in the discovery, acquisition, development and commercialization of therapeutic drugs for severely ill patients with significant unmet medical needs around the world.

Kiniksa Pharmaceuticals Address

CLARENDON HOUSE, 2 CHURCH STREET, HAMILTON, BM

Market Capitalization: 933 692 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -106 852 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -1.943

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: 2.501

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 8.43

Enterprise Value (EV) /Revenue

EV To EBITDA: -7.1

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 34470400

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.